ARZGY vs ISNPY: Which Is the Better Buy in 2026?

Last updated November 2026

Short answer

ISNPY is the larger of the two ($112.05B market cap): the incumbent the market prices for continued execution (8.80x forward earnings, beta 0.82). ARZGY is the smaller challenger ($71.09B), cheaper on forward earnings (5.84x): more room to run, but more to prove. If you believe ISNPY earns its premium (8.8x forward earnings, so the market expects more from it), ISNPY fits. If you believe in paying less for profit, ARZGY fits at 5.84x.

ARZGY vs ISNPY: the tie-breaker metrics

Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

MetricARZGYISNPYWhat it tells you
Market cap$71.09B$112.05BSize. The larger name is the incumbent; the smaller has more room to grow and more to prove.
Forward P/E5.848.80Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up.
Trailing P/E13.619.81Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price.
Beta0.670.82Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through.
Price vs 52-week range63% of range33% of rangeWhere today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why.
Price / book1.991.47How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price.

Reading it: ARZGY is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

Before you buy: how ARZGY and ISNPY affect your concentration

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ARZGY and ISNPY share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ARZGY and ISNPY exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

What does Assicurazioni Generali S.p.A. (ARZGY) do?

Assicurazioni Generali S.p.A., founded in Trieste in 1831, is one of Europe's three largest insurers by premiums, alongside Allianz and AXA. It writes life, savings and pension business (€61.9 billion of 2025 gross written premiums) and property and casualty cover (€36.2 billion), mainly in Italy, France, Germany, Austria, Switzerland, Spain and Central and Eastern Europe, with smaller operations in Asia and Latin America. A third leg is asset management: the group oversaw about €900 billion of assets at the end of 2025, including Generali Investments and the private bank Banca Generali, in which Generali owns just over 50% and which has passed €110 billion of client assets. Total 2025 gross written premiums were €98.1 billion, up 3.6%.

Full ARZGY guide

What does Intesa Sanpaolo (ISNPY) do?

Intesa Sanpaolo is Italy's largest banking group and one of the biggest in the eurozone by market value. It runs retail and corporate banking for millions of Italian households and companies, a large asset-management arm (Eurizon), a private bank (Fideuram), a life and property insurer, and subsidiary banks across Central and Eastern Europe and Egypt. US investors usually reach it through ISNPY, an over-the-counter American Depositary Receipt quoted in dollars, where one ADR equals six ordinary shares traded in Milan under ISP. In early November 2026 the ADR was about $41, which lined up with the Milan price of about €6.18 at a euro near $1.11, and the group's market value was about €107 billion. By November 20 the ADR had eased to $38.79, a market value of about $112 billion.

Full ISNPY guide

ARZGY vs ISNPY: how do they differ?

Both fit overlapping themes, but they are not interchangeable. Here is what each one depends on.

  • ARZGY drivers: Property and casualty pricing; Life and savings margins.
  • ISNPY drivers: Fees, wealth management and insurance; Shareholder distributions.

Which fits which kind of investor

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: Catastrophe exposure comes first. For ISNPY, the MPS offer is the largest near-term risk.

ARZGY or ISNPY: which should you pick?

If the story you believe is ARZGY's (Property and casualty pricing), ARZGY is the more direct way to own it; if it is ISNPY's (Fees, wealth management and insurance), ISNPY is. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ARZGY and ISNPY guides.

ARZGY vs ISNPY: the full fundamentals

ARZGY. On trailing adjusted earnings of roughly €3.05 a share, Generali trades at about 14 to 15 times earnings in Milan, broadly in line with Allianz and AXA. The ADR price follows the Milan share: one ADR equals half a share, so at €44.47 and about US$1.105 per euro the ADR sat near US$24.50 in mid-November; it closed at US$23.69 on 20 November. The 2025 dividend of €1.64 a share works out to €0.82 per ADR before Italian withholding tax. The Solvency II ratio was 211% at 30 September 2026, and the €500 million 2026 buyback is complete.

ISNPY. Intesa trades at about 10 times trailing earnings and around 9 times forward estimates, a modest multiple for a bank earning a return on tangible equity near 26%, and an estimated two times tangible book value. Analysts covering the Milan shares had a consensus target around €7.25 in September 2026, with RBC and Barclays among those lifting targets during the year. The ADR has traded between about $34 and $48 over the past year and at $38.79 on November 20, 2026 sat about 1% above where it stood twelve months earlier and about 19% below its level three months before, as the pending MPS share issue and the Italian tax increase have offset record profits. Dollar returns also depend on the euro, which was near $1.11 in early November.

Headline figures (approximate, November 2026): ARZGY shows gross written premiums (fy 2025) ~€98.1 billion, adjusted net profit (fy 2025) ~€4.32 billion, adjusted net profit (9m 2026) ~€3.68 billion (+12%), share price (13 nov milan / 20 nov adr) ~€44.47 / US$23.69; ISNPY shows share price (isnpy adr) $38.79 on November 20, 2026 (1 ADR = 6 Milan shares; Milan ~€6.18 in early November), market cap ~$112B (~€107B in early November), operating income (ttm) ~€28B, net income (ttm) ~€9.9B; 9M 2026 ~€8.2B, up 8.1%.

The bottom line: ARZGY vs ISNPY

ARZGY and ISNPY are related but distinct: same themes, different businesses and risks. Neither wins in the abstract, and whichever you pick is worth sizing so one theme does not take over your portfolio. Walnut can show your combined ARZGY and ISNPY exposure against your real portfolio. It is not an investment adviser.

Wondering how ARZGY or ISNPY fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Assicurazioni Generali S.p.A.

Ask Walnut's AI anything about ARZGY and see how it fits what you own.

FAQ

What is the difference between ARZGY and ISNPY?

+

Assicurazioni Generali S.p.A., founded in Trieste in 1831, is one of Europe's three largest insurers by premiums, alongside Allianz and AXA. Intesa Sanpaolo is Italy's largest banking group and one of the biggest in the eurozone by market value. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.

Is ARZGY or ISNPY the better stock?

+

Neither is universally better. ISNPY is the larger incumbent; ARZGY is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.

Which is cheaper, ARZGY or ISNPY?

+

On forward P/E (as of November 2026), ARZGY trades at 5.84x and ISNPY at 8.80x, so ARZGY is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.

Should you own both ARZGY and ISNPY?

+

Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.

What are the risks of ARZGY vs ISNPY?

+

ARZGY: Catastrophe exposure comes first. Floods, hail and storms in Europe cost Generali about €1.08 billion more in the first nine months of 2026 than a year earlier, and the third-quarter operating result missed consensus because of it. Reinsurance limits the damage from a single event but not from a run of bad seasons. Italian sovereign debt is the second exposure: Generali holds a large portfolio of Italian government bonds, so a widening of the BTP spread over German Bunds hits its solvency ratio and its share price together. Third is governance. Mediobanca, Delfin, UniCredit and Caltagirone each hold large stakes, Intesa's offer for Monte dei Paschi would move Mediobanca's ~13% stake to Intesa, and Italy's antitrust authority is still reviewing Intesa's commitments on Generali. Board fights consumed the 2022 and 2025 annual meetings and could return at the 2028 board renewal. Analysts are not uniformly positive either: Jefferies cut the stock to hold with a €38 target in September 2026. For ADR holders, the ADR is unsponsored and thinly traded on the OTC market, dividends are reduced by Italian withholding tax, and a weaker euro lowers both price and income in dollars. ISNPY: The MPS offer is the largest near-term risk. Issuing around 5 billion new shares only pays off if the cost savings and revenue gains arrive on schedule, and Italy's antitrust authority has asked for branch sales as a condition, which trims the benefit. Integration of MPS and the Mediobanca stake it holds could absorb management attention for years. Italian politics is the second risk: the 2026 Budget Law raised the tax burden on banks by about €0.9 billion this year, and Rome has a record of reaching for bank profits when it needs revenue. Intesa holds a large amount of Italian government debt, so a widening of the BTP spread would hit capital and funding costs. Net interest income still makes up more than half of operating income, so further ECB rate cuts would weigh on margins even though the bank expects NII to rise in 2027. For ISNPY specifically, the ADR is priced in dollars on an OTC market with thinner volume and wider spreads than Milan, dividends arrive after currency conversion and a 26% Italian withholding tax (partly reclaimable under the US treaty), and a stronger dollar reduces returns in dollar terms.

Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ARZGY or ISNPY; figures are approximate and dated (as of November 2026). Verify current data before investing.